Director Kemps-Polanco Reshema 🟢 acquired 2.0K shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) at $177.62 Transaction Date: May 08, 2026 | Filing ID: 000048
Schiller Mark C. 🔴 sold 117.5K shares (9 derivative) of Kezar Life Sciences, Inc. (KZR) at $22.80 ($1.7M) Transaction Date: May 11, 2026 | Filing ID: 000002